HeidelbaughJJKimAHChangRWalkerPC.Overutilization of proton-pump inhibitors: what the clinician needs to know. Ther Adv Gastroenterol2012;5(4):219-32.
2.
FreedbergDEKimLSYangY-X.The risks and benefits of long-term use of proton pump inhibitors: expert review and best practice advice from the American Gastroenterological Association. Gastroenterology2017;152(4):706-15.
3.
ThompsonWBlackCWelchVet al. Patient values and preferences surrounding proton pump inhibitor use: a scoping review. Patient2018;11(1):17-28.
4.
ReeveEToJHendrixIet al. Patient barriers to and enablers of deprescribing: a systematic review. Drugs Aging2013;30(10):793-807.
5.
StaceyDLégaréFLyddiattAet al. Translating evidence to facilitate shared decision making: development and usability of a consult decision aid prototype. Patient2016;9(6):571-82.
6.
StaceyDLégaréFColNFet al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev2014;(1):CD001431.
ThompsonWFarrellBWelchVet al. Should I continue taking my acid reflux medication? Design of a pilot before/after study evaluating a patient decision aid. Can Pharm J (Ott)2017;150(1):19-21.
SepuchaKRBorkhoffCMLallyJet al. Establishing the effectiveness of patient decision aids: key constructs and measurement instruments. BMC Med Inform Decis Mak2013;13(Suppl 2):S12.
11.
ShultzCGJimboM.Decision aid use in primary care: an overview and theory-based framework. Fam Med2015;47(9):679-92.
12.
ReeveEAndrewsJMWieseMDet al. Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Ann Pharmacother2015;49(1):29-38.
13.
SiroisCOuelletNReeveE.Community-dwelling older people’s attitudes towards deprescribing in Canada. Res Soc Adm Pharm2017;13(4):864-70.
